Table 3—

Degree of change from baseline in overall Asthma Quality of Life Questionnaire(AQLQ) scores at 52 weeks in patients receiving salmeterol/fluticasone propionate combination (SFC) or fluticasone propionate (FP), presented by individual strata and overall

Change in AQLQ scoreStratum 1Stratum 2Stratum 3Overall
SFCFPSFCFPSFCFPSFCFP
Subjects n218216301280291277810773
≥1.5122 (56)106 (49)120 (40)109 (39)121 (42)89 (32)363 (45)304 (39)
≥1.0–<1.535 (16)38 (18)67 (22)50 (18)52 (18)47 (17)154 (19)135 (17)
≥0.5–<1.024 (11)36 (17)58 (19)40 (14)51 (18)63 (23)133 (16)139 (18)
>0–<0.525 (11)20 (9)37 (12)44 (16)34 (12)46 (17)96 (12)110 (14)
≤012 (6)16 (7)19 (6)37 (13)33 (11)32 (12)64 (8)85 (11)
  • Data are presented as n (%), unless otherwise stated.